The city of Tianjin opens a reproductive laboratory that brings advanced reproductive medical technology to help increase the success rate of test tube babies in IVF Hospital, on August 8.
As the two-child policy come into effect, and given the delay in childbearing in urban areas, more and more women between 35 and 45 are expected to give birth. However, women over 35 may find it difficult to become pregnant because of the decline in ovarian reserve function and oocyte quality, which means they need to rely on assisted reproductive technologies.
The laboratory will use the technique of ovum transparent tape detection to measure the ova's development potential and to select the best ones for external fertilization as a way to raise the rate of fertilization.
The three to five days' in vitro cultivation can also improve the pregnancy rate and lower multiple pregnancy risks.
Prof. Barry Bell, director of Stanford University's Reproductive Center, and an iconic figure in research in human reproduction, has contributed to the cooperation.
He has developed the embryo screening technology which was selected as one of the top ten medical inventions of 2010.
The Tianjin IVF Hospital obtained the pilot run qualification of in vitro fertilization -- embryo transplant and intracytoplasmic sperm injection -- in June, 2016 and invited experts from China and other countries to further improve its professional skills.